U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07088328) titled 'Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial' on July 19.
Brief Summary: The aim of this study is to determine the value of Pentoxifylline for nephroprotection in these neonates with perinatal asphyxia, using cystatin C, regional oxygenation measured near infrared spectroscopy and renal Doppler sonography.
Study Start Date: July 30
Study Type: INTERVENTIONAL
Condition:
Hypoxic-Ischemic Encephalopathy
Neonatal Encephalopathy
Pentoxifylline Adverse Reaction
Intervention:
DRUG: Pentoxifylline
Intravenous administration for 3 days
OTHER: placebo distilled water
Intravenous administration for 3 days...